Loading…

Clinical Profile and Prognostic Markers of Acute on Chronic Liver Failure (ACLF): A Single-center Experience from East India

The aim of the study was to study the clinical profile of acute on chronic liver failure (ACLF) and establish Cell-free DNA (Cf DNA) as a predictor of the outcome of ACLF. In this prospective study, those patients who fulfilled EASL criteria were included. Cf DNA was estimated in 30 patients and com...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical and experimental hepatology 2023-11, Vol.13 (6), p.1017-1024
Main Authors: Halder, Prasenjit, Roy, Susree, Banerjee, Soma, Mandal, Syamsundar, Das, Kausik, Chowdhury, Abhijit, Mahiuddin Ahammed, Sk
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c456t-ec8c57419dfc5aeada3d7a4a506254efebadbc58a1bd3bd24abe0d56ee492b0e3
cites cdi_FETCH-LOGICAL-c456t-ec8c57419dfc5aeada3d7a4a506254efebadbc58a1bd3bd24abe0d56ee492b0e3
container_end_page 1024
container_issue 6
container_start_page 1017
container_title Journal of clinical and experimental hepatology
container_volume 13
creator Halder, Prasenjit
Roy, Susree
Banerjee, Soma
Mandal, Syamsundar
Das, Kausik
Chowdhury, Abhijit
Mahiuddin Ahammed, Sk
description The aim of the study was to study the clinical profile of acute on chronic liver failure (ACLF) and establish Cell-free DNA (Cf DNA) as a predictor of the outcome of ACLF. In this prospective study, those patients who fulfilled EASL criteria were included. Cf DNA was estimated in 30 patients and compared with the CLIF-C ACLF score. The median age of 132 consecutive ACLF patients was 40 years. The most common acute insult were sepsis (30.3%) and alcohol (22%). While alcohol (35.6%) and chronic HBV (14.3%) were the most common etiologies of cirrhosis. The overall mortality was 45.5% and 71.2% at 28 days and 90 days, respectively. Multiple regression analysis using the Cox proportional hazard model showed that heart rate (HR 1.06, 95% CI 1.04–1.08 P = 0.001), lung failure (HR 2.82, 95% CI 1.24–6.44, P = 0.02), and cell-free DNA (HR 2.70, 95% CI 1.17–6.24, P = 0.02) were independent predictors of mortality When Cf DNA was used to predict 28-day mortality, Cf DNA was found to have a higher AUC (AUROC 0.84, 95% CI 0.70-0.98, P = 0.001) than the CLIF-C-ACLF score (AUROC 0.81, 95% 0.66–0.97, P = 0.003). However, when 90-day mortality was compared, CLIF-C-ACLF score had a higher area under the curve (AUROC 0.93, 95% CI 0.83–1.00, P = 0.0001) than Cf DNA (AUROC 0.89, 95% CI 0.77–1.00, P = 0.0001). Alcohol and sepsis remain the most common causes of acute insult. Cf DNA is a better predictor of 28-day mortality, whereas CLIF-C ACLF is more accurate to predict 90-day mortality.
doi_str_mv 10.1016/j.jceh.2023.06.010
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10643518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0973688323001354</els_id><sourcerecordid>2891754093</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-ec8c57419dfc5aeada3d7a4a506254efebadbc58a1bd3bd24abe0d56ee492b0e3</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMo7rDuH_AgOa6H7s1nf4ggQzOjCyMK6jmkk-qZjD3JmHQPK_jj7XZ2F72YSwXqfd8q6kHoJSU5JbS42ed7A7ucEcZzUuSEkidowRjlGReSP0ULUpc8K6qKX6CrlPZkegVhgrDn6IKXdSmJkAv0q-mdd0b3-HMMnesBa2_n_9aHNDiDP-r4HWLCocNLMw6Ag8fNLobJhDfuBBGvtevHCPh62WzWr9_gJf7i_LaHzIAfpv7q7gjRgTeAuxgOeKXTgG-9dfoFetbpPsHVfb1E39arr82HbPPp_W2z3GRGyGLIwFRGloLWtjNSg7aa21ILLUnBpIAOWm1bIytNW8tby4RugVhZAIiatQT4JXp3zj2O7QHsvFfUvTpGd9DxpwraqX873u3UNpwUJYXgklZTwvV9Qgw_RkiDOrhkoO-1hzAmxaqallKQmk9SdpaaGFKK0D3OoUTN6NRezejUjE6RQk3oJtOrvzd8tDyAmgRvzwKY7nRyEFUyf25qXQQzKBvc__J_A17erE8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2891754093</pqid></control><display><type>article</type><title>Clinical Profile and Prognostic Markers of Acute on Chronic Liver Failure (ACLF): A Single-center Experience from East India</title><source>Elsevier</source><source>PubMed Central</source><creator>Halder, Prasenjit ; Roy, Susree ; Banerjee, Soma ; Mandal, Syamsundar ; Das, Kausik ; Chowdhury, Abhijit ; Mahiuddin Ahammed, Sk</creator><creatorcontrib>Halder, Prasenjit ; Roy, Susree ; Banerjee, Soma ; Mandal, Syamsundar ; Das, Kausik ; Chowdhury, Abhijit ; Mahiuddin Ahammed, Sk</creatorcontrib><description>The aim of the study was to study the clinical profile of acute on chronic liver failure (ACLF) and establish Cell-free DNA (Cf DNA) as a predictor of the outcome of ACLF. In this prospective study, those patients who fulfilled EASL criteria were included. Cf DNA was estimated in 30 patients and compared with the CLIF-C ACLF score. The median age of 132 consecutive ACLF patients was 40 years. The most common acute insult were sepsis (30.3%) and alcohol (22%). While alcohol (35.6%) and chronic HBV (14.3%) were the most common etiologies of cirrhosis. The overall mortality was 45.5% and 71.2% at 28 days and 90 days, respectively. Multiple regression analysis using the Cox proportional hazard model showed that heart rate (HR 1.06, 95% CI 1.04–1.08 P = 0.001), lung failure (HR 2.82, 95% CI 1.24–6.44, P = 0.02), and cell-free DNA (HR 2.70, 95% CI 1.17–6.24, P = 0.02) were independent predictors of mortality When Cf DNA was used to predict 28-day mortality, Cf DNA was found to have a higher AUC (AUROC 0.84, 95% CI 0.70-0.98, P = 0.001) than the CLIF-C-ACLF score (AUROC 0.81, 95% 0.66–0.97, P = 0.003). However, when 90-day mortality was compared, CLIF-C-ACLF score had a higher area under the curve (AUROC 0.93, 95% CI 0.83–1.00, P = 0.0001) than Cf DNA (AUROC 0.89, 95% CI 0.77–1.00, P = 0.0001). Alcohol and sepsis remain the most common causes of acute insult. Cf DNA is a better predictor of 28-day mortality, whereas CLIF-C ACLF is more accurate to predict 90-day mortality.</description><identifier>ISSN: 0973-6883</identifier><identifier>EISSN: 2213-3453</identifier><identifier>DOI: 10.1016/j.jceh.2023.06.010</identifier><identifier>PMID: 37975045</identifier><language>eng</language><publisher>India: Elsevier B.V</publisher><subject>ACLF ; acute on chronic liver failure ; cell free DNA ; Original ; prognostic marker</subject><ispartof>Journal of clinical and experimental hepatology, 2023-11, Vol.13 (6), p.1017-1024</ispartof><rights>2023 Indian National Association for Study of the Liver</rights><rights>2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.</rights><rights>2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved. 2023 Indian National Association for Study of the Liver</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-ec8c57419dfc5aeada3d7a4a506254efebadbc58a1bd3bd24abe0d56ee492b0e3</citedby><cites>FETCH-LOGICAL-c456t-ec8c57419dfc5aeada3d7a4a506254efebadbc58a1bd3bd24abe0d56ee492b0e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643518/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643518/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,27911,27912,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37975045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Halder, Prasenjit</creatorcontrib><creatorcontrib>Roy, Susree</creatorcontrib><creatorcontrib>Banerjee, Soma</creatorcontrib><creatorcontrib>Mandal, Syamsundar</creatorcontrib><creatorcontrib>Das, Kausik</creatorcontrib><creatorcontrib>Chowdhury, Abhijit</creatorcontrib><creatorcontrib>Mahiuddin Ahammed, Sk</creatorcontrib><title>Clinical Profile and Prognostic Markers of Acute on Chronic Liver Failure (ACLF): A Single-center Experience from East India</title><title>Journal of clinical and experimental hepatology</title><addtitle>J Clin Exp Hepatol</addtitle><description>The aim of the study was to study the clinical profile of acute on chronic liver failure (ACLF) and establish Cell-free DNA (Cf DNA) as a predictor of the outcome of ACLF. In this prospective study, those patients who fulfilled EASL criteria were included. Cf DNA was estimated in 30 patients and compared with the CLIF-C ACLF score. The median age of 132 consecutive ACLF patients was 40 years. The most common acute insult were sepsis (30.3%) and alcohol (22%). While alcohol (35.6%) and chronic HBV (14.3%) were the most common etiologies of cirrhosis. The overall mortality was 45.5% and 71.2% at 28 days and 90 days, respectively. Multiple regression analysis using the Cox proportional hazard model showed that heart rate (HR 1.06, 95% CI 1.04–1.08 P = 0.001), lung failure (HR 2.82, 95% CI 1.24–6.44, P = 0.02), and cell-free DNA (HR 2.70, 95% CI 1.17–6.24, P = 0.02) were independent predictors of mortality When Cf DNA was used to predict 28-day mortality, Cf DNA was found to have a higher AUC (AUROC 0.84, 95% CI 0.70-0.98, P = 0.001) than the CLIF-C-ACLF score (AUROC 0.81, 95% 0.66–0.97, P = 0.003). However, when 90-day mortality was compared, CLIF-C-ACLF score had a higher area under the curve (AUROC 0.93, 95% CI 0.83–1.00, P = 0.0001) than Cf DNA (AUROC 0.89, 95% CI 0.77–1.00, P = 0.0001). Alcohol and sepsis remain the most common causes of acute insult. Cf DNA is a better predictor of 28-day mortality, whereas CLIF-C ACLF is more accurate to predict 90-day mortality.</description><subject>ACLF</subject><subject>acute on chronic liver failure</subject><subject>cell free DNA</subject><subject>Original</subject><subject>prognostic marker</subject><issn>0973-6883</issn><issn>2213-3453</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kU2LFDEQhoMo7rDuH_AgOa6H7s1nf4ggQzOjCyMK6jmkk-qZjD3JmHQPK_jj7XZ2F72YSwXqfd8q6kHoJSU5JbS42ed7A7ucEcZzUuSEkidowRjlGReSP0ULUpc8K6qKX6CrlPZkegVhgrDn6IKXdSmJkAv0q-mdd0b3-HMMnesBa2_n_9aHNDiDP-r4HWLCocNLMw6Ag8fNLobJhDfuBBGvtevHCPh62WzWr9_gJf7i_LaHzIAfpv7q7gjRgTeAuxgOeKXTgG-9dfoFetbpPsHVfb1E39arr82HbPPp_W2z3GRGyGLIwFRGloLWtjNSg7aa21ILLUnBpIAOWm1bIytNW8tby4RugVhZAIiatQT4JXp3zj2O7QHsvFfUvTpGd9DxpwraqX873u3UNpwUJYXgklZTwvV9Qgw_RkiDOrhkoO-1hzAmxaqallKQmk9SdpaaGFKK0D3OoUTN6NRezejUjE6RQk3oJtOrvzd8tDyAmgRvzwKY7nRyEFUyf25qXQQzKBvc__J_A17erE8</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Halder, Prasenjit</creator><creator>Roy, Susree</creator><creator>Banerjee, Soma</creator><creator>Mandal, Syamsundar</creator><creator>Das, Kausik</creator><creator>Chowdhury, Abhijit</creator><creator>Mahiuddin Ahammed, Sk</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20231101</creationdate><title>Clinical Profile and Prognostic Markers of Acute on Chronic Liver Failure (ACLF): A Single-center Experience from East India</title><author>Halder, Prasenjit ; Roy, Susree ; Banerjee, Soma ; Mandal, Syamsundar ; Das, Kausik ; Chowdhury, Abhijit ; Mahiuddin Ahammed, Sk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-ec8c57419dfc5aeada3d7a4a506254efebadbc58a1bd3bd24abe0d56ee492b0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>ACLF</topic><topic>acute on chronic liver failure</topic><topic>cell free DNA</topic><topic>Original</topic><topic>prognostic marker</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Halder, Prasenjit</creatorcontrib><creatorcontrib>Roy, Susree</creatorcontrib><creatorcontrib>Banerjee, Soma</creatorcontrib><creatorcontrib>Mandal, Syamsundar</creatorcontrib><creatorcontrib>Das, Kausik</creatorcontrib><creatorcontrib>Chowdhury, Abhijit</creatorcontrib><creatorcontrib>Mahiuddin Ahammed, Sk</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical and experimental hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Halder, Prasenjit</au><au>Roy, Susree</au><au>Banerjee, Soma</au><au>Mandal, Syamsundar</au><au>Das, Kausik</au><au>Chowdhury, Abhijit</au><au>Mahiuddin Ahammed, Sk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Profile and Prognostic Markers of Acute on Chronic Liver Failure (ACLF): A Single-center Experience from East India</atitle><jtitle>Journal of clinical and experimental hepatology</jtitle><addtitle>J Clin Exp Hepatol</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>13</volume><issue>6</issue><spage>1017</spage><epage>1024</epage><pages>1017-1024</pages><issn>0973-6883</issn><eissn>2213-3453</eissn><abstract>The aim of the study was to study the clinical profile of acute on chronic liver failure (ACLF) and establish Cell-free DNA (Cf DNA) as a predictor of the outcome of ACLF. In this prospective study, those patients who fulfilled EASL criteria were included. Cf DNA was estimated in 30 patients and compared with the CLIF-C ACLF score. The median age of 132 consecutive ACLF patients was 40 years. The most common acute insult were sepsis (30.3%) and alcohol (22%). While alcohol (35.6%) and chronic HBV (14.3%) were the most common etiologies of cirrhosis. The overall mortality was 45.5% and 71.2% at 28 days and 90 days, respectively. Multiple regression analysis using the Cox proportional hazard model showed that heart rate (HR 1.06, 95% CI 1.04–1.08 P = 0.001), lung failure (HR 2.82, 95% CI 1.24–6.44, P = 0.02), and cell-free DNA (HR 2.70, 95% CI 1.17–6.24, P = 0.02) were independent predictors of mortality When Cf DNA was used to predict 28-day mortality, Cf DNA was found to have a higher AUC (AUROC 0.84, 95% CI 0.70-0.98, P = 0.001) than the CLIF-C-ACLF score (AUROC 0.81, 95% 0.66–0.97, P = 0.003). However, when 90-day mortality was compared, CLIF-C-ACLF score had a higher area under the curve (AUROC 0.93, 95% CI 0.83–1.00, P = 0.0001) than Cf DNA (AUROC 0.89, 95% CI 0.77–1.00, P = 0.0001). Alcohol and sepsis remain the most common causes of acute insult. Cf DNA is a better predictor of 28-day mortality, whereas CLIF-C ACLF is more accurate to predict 90-day mortality.</abstract><cop>India</cop><pub>Elsevier B.V</pub><pmid>37975045</pmid><doi>10.1016/j.jceh.2023.06.010</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-6883
ispartof Journal of clinical and experimental hepatology, 2023-11, Vol.13 (6), p.1017-1024
issn 0973-6883
2213-3453
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10643518
source Elsevier; PubMed Central
subjects ACLF
acute on chronic liver failure
cell free DNA
Original
prognostic marker
title Clinical Profile and Prognostic Markers of Acute on Chronic Liver Failure (ACLF): A Single-center Experience from East India
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T15%3A23%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Profile%20and%20Prognostic%20Markers%20of%20Acute%20on%20Chronic%20Liver%20Failure%20(ACLF):%20A%20Single-center%20Experience%20from%20East%20India&rft.jtitle=Journal%20of%20clinical%20and%20experimental%20hepatology&rft.au=Halder,%20Prasenjit&rft.date=2023-11-01&rft.volume=13&rft.issue=6&rft.spage=1017&rft.epage=1024&rft.pages=1017-1024&rft.issn=0973-6883&rft.eissn=2213-3453&rft_id=info:doi/10.1016/j.jceh.2023.06.010&rft_dat=%3Cproquest_pubme%3E2891754093%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c456t-ec8c57419dfc5aeada3d7a4a506254efebadbc58a1bd3bd24abe0d56ee492b0e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2891754093&rft_id=info:pmid/37975045&rfr_iscdi=true